norfloxacin has been researched along with Gastroenteritis in 9 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Gastroenteritis: INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although theoretically the spectrum of antimicrobial quinolone antibiotics are at low risk of producing Clostridium difficile overgrowth and diarrhea, a patient developed this clinical problem while receiving norfloxacin." | 7.68 | Clostridium difficile-associated diarrhea after norfloxacin. ( Craig, RM; Ehrenpreis, ED; Lievens, MW, 1990) |
| "or t." | 3.76 | World-wide clinical experience with norfloxacin: efficacy and safety. ( Corrado, M; Hoagland, V; Sabbaj, J; Wang, C, 1986) |
| "Although theoretically the spectrum of antimicrobial quinolone antibiotics are at low risk of producing Clostridium difficile overgrowth and diarrhea, a patient developed this clinical problem while receiving norfloxacin." | 3.68 | Clostridium difficile-associated diarrhea after norfloxacin. ( Craig, RM; Ehrenpreis, ED; Lievens, MW, 1990) |
| "The pharmacokinetics of 400 mg norfloxacin administered orally were studied in 19 patients both during the acute phase of bacterial gastroenteritis and during convalescence, after normalization of bowel movements." | 3.67 | Consequences of diarrhoeal disease on the pharmacokinetics of norfloxacin. ( Bergan, T; Cheong, MK; Lolekha, S; Patancharoen, S; Poh, CL, 1988) |
| "To systematically review the efficacy and safety of Huoxiang Zhengqi Pills combined with Western medicine in the treatment of acute gastroenteritis." | 2.61 | [Systematic review and Meta-analysis of Huoxiang Zhengqi Pills combined with Western medicine for acute gastroenteritis]. ( Li, HM; Liao, X; Wang, GQ; Xie, YM; Yu, DD; Zhang, YL; Zhao, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, DD | 1 |
| Liao, X | 1 |
| Xie, YM | 1 |
| Li, HM | 1 |
| Zhang, YL | 1 |
| Wang, GQ | 1 |
| Zhao, J | 1 |
| Padeĭskaia, EN | 1 |
| Diez-Enciso, M | 1 |
| Mas-Jimenez, G | 1 |
| Velasco-Cerrudo, A | 1 |
| Gutierrez-Altes, A | 1 |
| Pitkäjärvi, T | 1 |
| Kujanne, E | 1 |
| Sillantaka, I | 1 |
| Lumio, J | 1 |
| Ehrenpreis, ED | 1 |
| Lievens, MW | 1 |
| Craig, RM | 1 |
| Murray, BE | 1 |
| Bayeli, PF | 1 |
| Corsini, P | 1 |
| Marchettini, G | 1 |
| Abate, L | 1 |
| Croci, F | 1 |
| Bergan, T | 1 |
| Lolekha, S | 1 |
| Cheong, MK | 1 |
| Poh, CL | 1 |
| Patancharoen, S | 1 |
| Wang, C | 1 |
| Sabbaj, J | 1 |
| Corrado, M | 1 |
| Hoagland, V | 1 |
4 reviews available for norfloxacin and Gastroenteritis
| Article | Year |
|---|---|
[Systematic review and Meta-analysis of Huoxiang Zhengqi Pills combined with Western medicine for acute gastroenteritis].
Topics: Drugs, Chinese Herbal; Gastroenteritis; Humans; Norfloxacin; Randomized Controlled Trials as Topic; | 2019 |
[Norfloxacin: more than 20 years of clinical use, the results and place among fluoroquinolones in modern chemotherapy for infections].
Topics: Anti-Infective Agents; Communicable Diseases; Enterobacteriaceae; Female Urogenital Diseases; Gastro | 2003 |
Quinolones and the gastrointestinal tract.
Topics: Agranulocytosis; Anti-Infective Agents; Bacterial Infections; Biliary Tract Diseases; Diarrhea; Drug | 1989 |
World-wide clinical experience with norfloxacin: efficacy and safety.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Diarrhea; Gastroente | 1986 |
2 trials available for norfloxacin and Gastroenteritis
| Article | Year |
|---|---|
Norfloxacin and Salmonella excretion in acute gastroenteritis--a 6-month follow-up study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Carrier State; Double-Blind Method; F | 1996 |
World-wide clinical experience with norfloxacin: efficacy and safety.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Diarrhea; Gastroente | 1986 |
4 other studies available for norfloxacin and Gastroenteritis
| Article | Year |
|---|---|
Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Gastroenteritis; Humans; Microbial Sensit | 1984 |
Clostridium difficile-associated diarrhea after norfloxacin.
Topics: Aged; Clostridium Infections; Diarrhea; Gastroenteritis; Humans; Male; Norfloxacin | 1990 |
[Clinical study of intestinal infections treated with norfloxacin].
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Drug Evaluation; Feces; Female; Gast | 1987 |
Consequences of diarrhoeal disease on the pharmacokinetics of norfloxacin.
Topics: Adolescent; Adult; Biological Availability; Diarrhea; Gastroenteritis; Humans; Norfloxacin | 1988 |